Arrowhead Pharmaceuticals, Inc 10-K for FY2021
Arrowhead Pharmaceuticals, Inc. (ARWR)
10-K
2021-11-22
For: 2021-09-30
View Original
Added on
April 08, 2026
About this 10-K
Arrowhead Pharmaceuticals, Inc filed this 10-K on November 22, 2021, covering the fiscal year ended September 30, 2021 (FY2021).
Headline figures
Fiscal year ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $138.29M
- up 57.2% from $87.99M a year earlier
- Net loss
- $140.85M
- compared with a net loss of $84.55M a year earlier
- Diluted EPS
- -$1.36
- compared with -$0.84 a year earlier